CG Oncology Balance Sheet Health
Financial Health criteria checks 5/6
CG Oncology has a total shareholder equity of $536.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $552.5M and $15.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$540.71m |
| Equity | US$536.77m |
| Total liabilities | US$15.70m |
| Total assets | US$552.47m |
Recent financial health updates
Recent updates
Companies Like CG Oncology (NASDAQ:CGON) Are In A Position To Invest In Growth
Oct 04
CG Oncology: Promising Data, But Looks Expensive
Aug 26CG Oncology, Inc. (NASDAQ:CGON) Shares Could Be 42% Below Their Intrinsic Value Estimate
Jul 25CG Oncology Bringing Undervalued Innovation To Bladder Cancer
Jul 09CG Oncology: ASCO Play And Top-Line Data End Of 2024 Could Drive Further Value
May 06Financial Position Analysis
Short Term Liabilities: CGON's short term assets ($552.1M) exceed its short term liabilities ($15.6M).
Long Term Liabilities: CGON's short term assets ($552.1M) exceed its long term liabilities ($71.0K).
Debt to Equity History and Analysis
Debt Level: CGON is debt free.
Reducing Debt: CGON had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CGON has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if CGON has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.